Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ophthalmology

Free Subscription 25.04.2022 1 Am J Ophthalmol 14 BMC Ophthalmol 15 Br J Ophthalmol 6 Eur J Ophthalmol 16 Exp Eye Res 48 Eye (Lond) 21 Graefes Arch Clin Exp Ophthalmol 4 Int Ophthalmol 4 Invest Ophthalmol Vis Sci 1 J Cataract Refract Surg 2 J Glaucoma 3 J Ocul Pharmacol Ther 2 N Engl J Med 11 Ophthalmic Plast Reconstr Surg 9 Ophthalmol Glaucoma 4 Ophthalmol Retina 2 Ophthalmology 10 PLoS One 5 Proc Natl Acad Sci U S A 10 Retina 1 Surv Ophthalmol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. BARBONI P, Amore G, Cascavilla ML, Battista M, et al
   The pattern of retinal ganglion cell loss in Wolfram syndrome is distinct from mitochondrial optic neuropathies.
   Am J Ophthalmol. 2022 Apr 19. pii: S0002-9394(22)00119.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

2. SAKAI A, Tagami M, Misawa N, Yamamoto M, et al
   Safety and efficacy of 27-gauge transconjunctival vitrectomy for the diagnosis of posterior uveitis or pan uveitis of unknown origin.
   BMC Ophthalmol. 2022;22:178.
   PubMed         Abstract available
   
   
3. MOON J, Lee Y, Yoon CH, Kim MK, et al
   Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome.
   BMC Ophthalmol. 2022;22:179.
   PubMed         Abstract available
   
   
4. ISHIDA Y, Ota N, Tsuboi K, Kamei M, et al
   Dissociated optic nerve fiber layer-like appearance indicating an internal limiting membrane defect associated with an epiretinal membrane: two case reports.
   BMC Ophthalmol. 2022;22:169.
   PubMed         Abstract available
   
   
5. SHIN JH, Lee JW, Lim SH, Yoon BW, et al
   The microbiomes of the eyelid and buccal area of patients with uveitic glaucoma.
   BMC Ophthalmol. 2022;22:170.
   PubMed         Abstract available
   
   
6. ZHAO J, Li Z, Liu Y, Han X, et al
   Application of prechop technique in phacoemulsification for cataract patients with highly liquefied vitreous: a retrospective study.
   BMC Ophthalmol. 2022;22:167.
   PubMed         Abstract available
   
   
7. YANG TH, Lin MC
   Using diffuse weighted image and apparent diffusion coefficient in MRI for diagnosis of posterior ischemic optic neuropathy in a young male: a case report and literature review.
   BMC Ophthalmol. 2022;22:168.
   PubMed         Abstract available
   
   
8. GUO R, Huang D, Ji J, Liu W, et al
   A novel mutation GJA8 NM_005267.5: c.124G > A, p.(E42K) causing congenital nuclear cataract.
   BMC Ophthalmol. 2022;22:172.
   PubMed         Abstract available
   
   
9. LIN Z, Song Z, Zhao Z, Ke Z, et al
   Reversed scleral tunnel technique for repair of iridodialysis after blunt force trauma: a retrospective clinical study.
   BMC Ophthalmol. 2022;22:171.
   PubMed         Abstract available
   
   
10. STOLL N, Di Foggia E, Speeg-Schatz C, Meunier H, et al
    Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test.
    BMC Ophthalmol. 2022;22:180.
    PubMed         Abstract available
    
    
11. LIN W, Gu T, Bi H, Du B, et al
    The treatment zone decentration and corneal refractive profile changes in children undergoing orthokeratology treatment.
    BMC Ophthalmol. 2022;22:177.
    PubMed         Abstract available
    
    
12. FENG J, Yu J, Chen Q, Zhou H, et al
    Long-term surgical outcomes and prognostic factors of foveal detachment in pathologic myopia: based on the ATN classification.
    BMC Ophthalmol. 2022;22:175.
    PubMed         Abstract available
    
    
13. GUL FC, Kobat SG, Celik F, Aydin S, et al
    Plasma and aqueous levels of alarin and adipsin in patients with and without diabetic retinopathy.
    BMC Ophthalmol. 2022;22:176.
    PubMed         Abstract available
    
    
14. WANG JD, Zhang JS, Li M, Mao YY, et al
    Comparison of different pupil dilatation methods for phacoemulsification in eyes with a small pupil.
    BMC Ophthalmol. 2022;22:173.
    PubMed         Abstract available
    
    
15. SUN N, Wang C, Linghu W, Li X, et al
    Demographic and clinical features of pediatric uveitis and scleritis at a tertiary referral center in China.
    BMC Ophthalmol. 2022;22:174.
    PubMed         Abstract available
    
    

    
    Br J Ophthalmol

16. MA Y, Zhang X, He F, Ma X, et al
    Visual impairment in rural and migrant Chinese school-going children: prevalence, severity, correction and associations.
    Br J Ophthalmol. 2022;106:275-280.
    PubMed         Abstract available
    
    
17. OYEMADE KA, Xu TT, Lopez Dominguez J, Dumbrava MG, et al
    Population-based incidence of intraocular tumours in Olmsted County, Minnesota.
    Br J Ophthalmol. 2022 Apr 21. pii: bjophthalmol-2021-320682.
    PubMed         Abstract available
    
    
18. SUN MT, Singh K, Wang SY
    Changes in glaucoma management following visual field testing and optical coherence tomography.
    Br J Ophthalmol. 2022 Apr 21. pii: bjophthalmol-2021-321010.
    PubMed         Abstract available
    
    
19. MANSOURI K, Gillmann K, Rao HL, Szurman P, et al
    Measurement of intraocular temperature in glaucoma: week-day and seasonal fluctuations.
    Br J Ophthalmol. 2022 Apr 20. pii: bjophthalmol-2021-320495.
    PubMed         Abstract available
    
    
20. LIU F, Niu L, Guo J, Jian W, et al
    Quantitative evaluation of retinal and choroidal vascularity and retrobulbar blood flow in patients with myopic anisometropia by CDI and OCTA.
    Br J Ophthalmol. 2022 Apr 20. pii: bjophthalmol-2021-320597.
    PubMed         Abstract available
    
    
21. CORE JQ, Hua P, Daniel E, Grunwald JE, et al
    Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
    Br J Ophthalmol. 2022 Apr 15. pii: bjophthalmol-2021-320665.
    PubMed         Abstract available
    
    
22. NUSINOVICI S, Zhang L, Chai X, Zhou L, et al
    Machine learning to determine relative contribution of modifiable and non-modifiable risk factors of major eye diseases.
    Br J Ophthalmol. 2022;106:267-274.
    PubMed         Abstract available
    
    
23. KUBOTA R, Birch DG, Gregory JK, Koester JM, et al
    Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease.
    Br J Ophthalmol. 2022;106:403-408.
    PubMed         Abstract available
    
    
24. PAPA V, van der Meulen I, Rottey S, Sallet G, et al
    Safety and tolerability of topical polyhexamethylene biguanide: a randomised clinical trial in healthy adult volunteers.
    Br J Ophthalmol. 2022;106:190-196.
    PubMed         Abstract available
    
    
25. PRIMAVERA L, Canto-Cerdan M, Alio JL, Alio Del Barrio JL, et al
    Influence of age on small incision lenticule extraction outcomes.
    Br J Ophthalmol. 2022;106:341-348.
    PubMed         Abstract available
    
    
26. KILGORE KP, Wang F, Stern NC, Jamali Dogahe S, et al
    Health-related quality of life in Ahmed FP7, and Baerveldt 250 and 350 patients compared with medical controls.
    Br J Ophthalmol. 2022;106:356-361.
    PubMed         Abstract available
    
    
27. DUKE RE, Nwachukuw J, Torty C, Okorie U, et al
    Visual impairment and perceptual visual disorders in children with cerebral palsy in Nigeria.
    Br J Ophthalmol. 2022;106:427-434.
    PubMed         Abstract available
    
    
28. LIM ZW, Chee ML, Lim SH, Thakur S, et al
    Normative profiles of neuroretinal rim area in a multiethnic Asian population: the Singapore Epidemiology of Eye Diseases study.
    Br J Ophthalmol. 2022;106:381-387.
    PubMed         Abstract available
    
    
29. SAFIZADEH M, Shaabani A, Kamalipour A, Fard MA, et al
    Optic nerve head vessel density in different stages of pseudoexfoliation disease.
    Br J Ophthalmol. 2022;106:223-228.
    PubMed         Abstract available
    
    
30. BOVONE C, Nahum Y, Scorcia V, Giannaccare G, et al
    Stromal peeling for deep anterior lamellar keratoplasty in post-penetrating keratoplasty eyes.
    Br J Ophthalmol. 2022;106:336-340.
    PubMed         Abstract available
    
    

    
    Eur J Ophthalmol

31. CALONGE M, Sahyoun M, Baillif S, Gain P, et al
    Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease.
    Eur J Ophthalmol. 2022 Apr 21:11206721221096321. doi: 10.1177/11206721221096321.
    PubMed         Abstract available
    
    
32. DETTORAKI M, Droutsas K, Lazaridis A, Moschos MM, et al
    Evaluation of macular function and morphology following accelerated collagen cross-linking in progressive keratoconus.
    Eur J Ophthalmol. 2022 Apr 21:11206721221094880. doi: 10.1177/11206721221094880.
    PubMed         Abstract available
    
    
33. FOUAD YA, Mekkawy MO, Sallam AB
    Bilateral macular retinitis in patients with presumed rift valley fever from Sudan: A case series.
    Eur J Ophthalmol. 2022 Apr 21:11206721221096305. doi: 10.1177/11206721221096305.
    PubMed         Abstract available
    
    
34. GATTOUSSI S, Romdhane BB, Seneclauze A, Rougier MB, et al
    Choroidal granulomas due to Bartonella henselae infection: A case series.
    Eur J Ophthalmol. 2022 Apr 21:11206721221091376. doi: 10.1177/11206721221091376.
    PubMed         Abstract available
    
    
35. GAMALELDIN SA, ElShazly MI, Salama MM
    Trocar-assisted flanged transconjunctival intrascleral sutureless intraocular lens fixation.
    Eur J Ophthalmol. 2022 Apr 18:11206721221094398. doi: 10.1177/11206721221094398.
    PubMed         Abstract available
    
    
36. YE Y, Yang F, Ding L, Xia F, et al
    Comparison of Icare HOME and non-contact tonometer in intraocular pressure measurement in the early stage after ICL V4c implantation.
    Eur J Ophthalmol. 2022 Apr 14:11206721221093990. doi: 10.1177/11206721221093990.
    PubMed         Abstract available
    
    

    
    Exp Eye Res

37. KATIYAR P, Stachon T, Fries FN, Parow F, et al
    Decreased FABP5 and DSG1 protein expression following PAX6 knockdown of differentiated human limbal epithelial cells.
    Exp Eye Res. 2022;215:108904.
    PubMed         Abstract available
    
    
38. HU J, Yao Y, Huang J, Qian J, et al
    Erxian Decoction modulates Th17/Treg cells differentiation through LFA-1/ICAM-1/STAT3 pathway in menopausal dry eye disease.
    Exp Eye Res. 2022;215:108890.
    PubMed         Abstract available
    
    
39. KALOGEROU M, Ioannou S, Kolovos P, Prokopiou E, et al
    Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy.
    Exp Eye Res. 2022;215:108901.
    PubMed         Abstract available
    
    
40. REBECCA M, Sripriya K, Bharathselvi M, Shantha B, et al
    Increased Desmosine in the lens capsules is associated with augmented elastin turnover in Pseudoexfoliation syndrome.
    Exp Eye Res. 2022;215:108898.
    PubMed         Abstract available
    
    
41. HAMANAKA T, Chin S, Shinmei Y, Sakurai T, et al
    Histological analysis of trabeculotomy - An investigation on the intraocular pressure lowering mechanism.
    Exp Eye Res. 2022 Apr 16:109079. doi: 10.1016/j.exer.2022.109079.
    PubMed         Abstract available
    
    
42. YAN J, Li Y, Zhang T, Shen Y, et al
    Numb deficiency impairs retinal structure and visual function in mice.
    Exp Eye Res. 2022;219:109066.
    PubMed         Abstract available
    
    
43. GUAIQUIL VH, Xiao C, Lara D, Dimailig G, et al
    Expression of axon guidance ligands and their receptors in the cornea and trigeminal ganglia and their recovery after corneal epithelium injury.
    Exp Eye Res. 2022 Apr 12:109054. doi: 10.1016/j.exer.2022.109054.
    PubMed         Abstract available
    
    
44. MUGISHO OO, Green CR
    The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics.
    Exp Eye Res. 2022;215:108911.
    PubMed         Abstract available
    
    
45. CHENG Z, Li Y, Wang K, Zhu X, et al
    Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human Muller cells against oxidative injury.
    Exp Eye Res. 2022;215:108906.
    PubMed         Abstract available
    
    
46. OZAKI E, Delaney C, Campbell M, Doyle SL, et al
    Minocycline suppresses disease-associated microglia (DAM) in a model of photoreceptor cell degeneration.
    Exp Eye Res. 2022;217:108953.
    PubMed         Abstract available
    
    
47. UBELS JL, Lin CM, Antonetti DA, Diaz-Coranguez M, et al
    Structure and function of the retina of low-density lipoprotein receptor-related protein 5 (Lrp5)-deficient rats.
    Exp Eye Res. 2022;217:108977.
    PubMed         Abstract available
    
    
48. MESSMER EM
    Pathophysiology of dry eye disease and novel therapeutic targets.
    Exp Eye Res. 2022;217:108944.
    PubMed         Abstract available
    
    
49. SREEKUMAR PG, Reddy ST, Hinton DR, Kannan R, et al
    Mechanisms of RPE senescence and potential role of alphaB crystallin peptide as a senolytic agent in experimental AMD.
    Exp Eye Res. 2022;215:108918.
    PubMed         Abstract available
    
    
50. MOROZUMI W, Aoshima K, Inagaki S, Iwata Y, et al
    Piezo1 activation induces fibronectin reduction and PGF2alpha secretion via arachidonic acid cascade.
    Exp Eye Res. 2022;215:108917.
    PubMed         Abstract available
    
    
51. WAXMAN S, Brazile BL, Yang B, Lee PY, et al
    Lamina cribrosa vessel and collagen beam networks are distinct.
    Exp Eye Res. 2022;215:108916.
    PubMed         Abstract available
    
    
52. LLEDO VE, Alkozi HA, Sanchez-Naves J, Fernandez-Torres MA, et al
    Melatonin counteracts oxidative damage in lens by regulation of Nrf2 and NLRP3 inflammasome activity.
    Exp Eye Res. 2022;215:108912.
    PubMed         Abstract available
    
    

    
    Eye (Lond)

53. ASAOKA R, Miyata M, Oishi A, Fujino Y, et al
    Relationship between visual acuity and visual field and its reproducibility in patients with retinitis pigmentosa.
    Eye (Lond). 2022 Apr 20. pii: 10.1038/s41433-022-02043.
    PubMed         Abstract available
    
    
54. DHOOT DS, Moini H, Reed K, Du W, et al
    Functional outcomes of sustained improvement on Diabetic Retinopathy Severity Scale with intravitreal aflibercept in the VISTA and VIVID trials.
    Eye (Lond). 2022 Apr 19. pii: 10.1038/s41433-022-02058.
    PubMed         Abstract available
    
    
55. PATEL RD, Burdon MA
    Isolated third cranial nerve palsies-modern management principles.
    Eye (Lond). 2022;36:232-233.
    PubMed        
    
    
56. ANG T, Juniat V, Selva D
    Autoimmune markers in screening for orbital inflammatory disease.
    Eye (Lond). 2022 Apr 19. pii: 10.1038/s41433-022-02068.
    PubMed         Abstract available
    
    
57. LI F, Xiang W, Zhang L, Pan W, et al
    Joint optic disk and cup segmentation for glaucoma screening using a region-based deep learning network.
    Eye (Lond). 2022 Apr 18. pii: 10.1038/s41433-022-02055.
    PubMed         Abstract available
    
    
58. VUJOSEVIC S, Parra MM, Hartnett ME, O'Toole L, et al
    Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.
    Eye (Lond). 2022 Apr 15. pii: 10.1038/s41433-022-02056.
    PubMed         Abstract available
    
    
59. GOLOB-SCHWARZL N, Woltsche N, Armento A, Wolf P, et al
    SARS-CoV-2 spike protein functionally interacts with primary human conjunctival epithelial cells to induce a pro-inflammatory response.
    Eye (Lond). 2022 Apr 15. pii: 10.1038/s41433-022-02066.
    PubMed        
    
    
60. KELLY DS, Ganti T, Ramsey DJ
    Underdiagnosis of risk of glaucoma in patients with retinal vein occlusions.
    Eye (Lond). 2022 Apr 15. pii: 10.1038/s41433-022-02063.
    PubMed        
    
    
61. GARCIN T, Gain P, Thuret G
    Femtosecond laser-cut autologous anterior lens capsule transplantation to treat refractory macular holes.
    Eye (Lond). 2022 Apr 15. pii: 10.1038/s41433-022-02062.
    PubMed         Abstract available
    
    
62. FERRARA M, Adams W, Kotagiri A
    Melanoma-associated retinopathy after starting immunotherapy for metastatic cutaneous melanoma.
    Eye (Lond). 2022 Apr 15. pii: 10.1038/s41433-022-02057.
    PubMed        
    
    
63. VENKATESH R, Agrawal S, Reddy NG, Mishra P, et al
    Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).
    Eye (Lond). 2022 Apr 14. pii: 10.1038/s41433-022-02065.
    PubMed         Abstract available
    
    
64. KAWAI K, Miyata M, Ooto S, Tamura H, et al
    Macular atrophy at 5 years after photodynamic therapy for polypoidal choroidal vasculopathy.
    Eye (Lond). 2022 Apr 14. pii: 10.1038/s41433-022-02067.
    PubMed         Abstract available
    
    
65. CLARE AJ, Liu J, Copland DA, Theodoropoulou S, et al
    Unravelling the therapeutic potential of IL-33 for atrophic AMD.
    Eye (Lond). 2022;36:266-272.
    PubMed         Abstract available
    
    
66. LOCKINGTON D, Saleh GM, Spencer AF, Ferris J, et al
    Dedicated time and resources are required to address variable engagement with ophthalmic simulation opportunities.
    Eye (Lond). 2022 Apr 19. pii: 10.1038/s41433-022-02059.
    PubMed        
    
    
67. NOROUZPOUR A
    Light exposure in acute central serous chorioretinopathy.
    Eye (Lond). 2022;36:243.
    PubMed        
    
    
68. SCANLON PH, Norridge CFE, Donachie PHJ, Mohamed Q, et al
    Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre.
    Eye (Lond). 2022;36:646-648.
    PubMed        
    
    
69. SEN S, Singh P, Saxena R
    Management of amblyopia in pediatric patients: Current insights.
    Eye (Lond). 2022;36:44-56.
    PubMed         Abstract available
    
    
70. TALKS SJ, Stratton I, Peto T, Lotery A, et al
    Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years.
    Eye (Lond). 2022;36:72-77.
    PubMed         Abstract available
    
    
71. ZUR D, Loewenstein A
    Should we still be performing macular laser for non-centre involving diabetic macular oedema? Yes.
    Eye (Lond). 2022;36:483-484.
    PubMed        
    
    
72. FENNER BJ, Cheung CMG, Sim SS, Lee WK, et al
    Evolving treatment paradigms for PCV.
    Eye (Lond). 2022;36:257-265.
    PubMed         Abstract available
    
    
73. TROTT M, Smith L, Veronese N, Pizzol D, et al
    Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.
    Eye (Lond). 2022;36:369-378.
    PubMed         Abstract available
    
    
74. CHUA PY, Sandinha MT, Steel DH
    Idiopathic epiretinal membrane: progression and timing of surgery.
    Eye (Lond). 2022;36:495-503.
    PubMed         Abstract available
    
    
75. DESAI D, Dugel PU
    Complement cascade inhibition in geographic atrophy: a review.
    Eye (Lond). 2022;36:294-302.
    PubMed         Abstract available
    
    
76. IGLICKI M, Gonzalez DP, Loewenstein A, Zur D, et al
    Next-generation anti-VEGF agents for diabetic macular oedema.
    Eye (Lond). 2022;36:273-277.
    PubMed         Abstract available
    
    
77. PAULEIKHOFF D, Pauleikhoff L, Chew EY
    Imaging endpoints for clinical trials in MacTel type 2.
    Eye (Lond). 2022;36:284-293.
    PubMed         Abstract available
    
    
78. DE ROSSI G, Da Vitoria Lobo ME, Greenwood J, Moss SE, et al
    LRG1 as a novel therapeutic target in eye disease.
    Eye (Lond). 2022;36:328-340.
    PubMed         Abstract available
    
    
79. NOLAN ND, Caruso SM, Cui X, Tsang SH, et al
    Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors.
    Eye (Lond). 2022;36:278-283.
    PubMed         Abstract available
    
    
80. CHARBEL ISSA P, Hess K
    The complexity of visual dysfunction in patients with pseudoxanthoma elasticum.
    Eye (Lond). 2022;36:492-494.
    PubMed        
    
    
81. MUELLER I, Talks JS
    Should we still be performing macular laser for non-centre involving diabetic macular oedema? No.
    Eye (Lond). 2022;36:485-486.
    PubMed        
    
    
82. LOTERY A
    Can we classify central serous chorioretinopathy better? Yes we can.
    Eye (Lond). 2022;36:487.
    PubMed        
    
    
83. ARORA S, Maltsev DS, Sahoo NK, Parameshwarappa DC, et al
    Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy.
    Eye (Lond). 2022;36:517-523.
    PubMed         Abstract available
    
    
84. CHAKRABORTY D, Mondal S, Parachuri N, Kumar N, et al
    Brolucizumab-early experience with early extended interval regime in chronic centre involved diabetic macular oedema.
    Eye (Lond). 2022;36:358-360.
    PubMed        
    
    
85. SHARMA A, Parachuri N, Kumar N, Kuppermann BD, et al
    The Port Delivery System with ranibizumab-journey of mitigating vitreous hemorrhage.
    Eye (Lond). 2022;36:488-489.
    PubMed        
    
    
86. HERBORT CP JR, Tugal-Tutkun I, Abu-El-Asrar A, Gupta A, et al
    Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.
    Eye (Lond). 2022;36:29-43.
    PubMed         Abstract available
    
    
87. NALAGATLA N, Davies R, Connolly J, Cauchi P, et al
    A National Audit of Uveal Melanoma Referrals in Scotland.
    Eye (Lond). 2022;36:649-650.
    PubMed        
    
    
88. GREWAL MK, Chandra S, Gurudas S, Rasheed R, et al
    Functional clinical endpoints and their correlations in eyes with AMD with and without subretinal drusenoid deposits-a pilot study.
    Eye (Lond). 2022;36:398-406.
    PubMed         Abstract available
    
    
89. NESEMANN JM, Kandel RP, Byanju R, Poudyal B, et al
    Association of visual impairment with disability: a population-based study.
    Eye (Lond). 2022;36:540-546.
    PubMed         Abstract available
    
    
90. AHN YJ, Park YY, Shin SY
    Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in children.
    Eye (Lond). 2022;36:533-539.
    PubMed         Abstract available
    
    
91. MANSOUR AM, Ahmed IIK, Charbaji AR, Mansour HA, et al
    Associations in corticocapsular adhesions.
    Eye (Lond). 2022;36:193-197.
    PubMed         Abstract available
    
    
92. ROMKENS HCS, Beckers HJM, Schouten JSAG, Berendschot TTJM, et al
    Effect of combined water drinking test and dark room provocative testing in Caucasian eyes with narrow angles.
    Eye (Lond). 2022;36:167-174.
    PubMed         Abstract available
    
    
93. SHAPIRA Y, Worrell E, Litwin AS, Malhotra R, et al
    The UK National Artificial Eye Questionnaire Study: predictors of artificial eye wearers' experience Part 2 - visual function and quality of life.
    Eye (Lond). 2022;36:140-147.
    PubMed         Abstract available
    
    
94. XIE X, Sultan W, Corradetti G, Lee JY, et al
    Assessing accommodative presbyopic biometric changes of the entire anterior segment using single swept-source OCT image acquisitions.
    Eye (Lond). 2022;36:119-128.
    PubMed         Abstract available
    
    
95. LUO KS, Xie A, Yang JJ, Shen EP, et al
    Critical value of Demodex count per lash for symptomatic and clinical improvement of Demodex blepharitis.
    Eye (Lond). 2022;36:663-665.
    PubMed        
    
    
96. HE B, Iovieno A, Etminan M, Kezouh A, et al
    Effects of hormonal contraceptives on dry eye disease: a population-based study.
    Eye (Lond). 2022;36:634-638.
    PubMed         Abstract available
    
    
97. SHETH J
    Comment on "Drusen and pachydrusen: the definition, pathogenesis, and clinical significance".
    Eye (Lond). 2022;36:229.
    PubMed        
    
    
98. OKADA M
    Perfect use versus typical use: translating outcomes in the treatment of diabetic macular oedema.
    Eye (Lond). 2022;36:1-2.
    PubMed        
    
    
99. MOSTAFA I, Al-Zubaidy M, Ghareeb A, Song A, et al
    Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR).
    Eye (Lond). 2022;36:352-353.
    PubMed        
    
    
100. ZHANG X, Sivaprasad S
     Response to 'Comment on 'Drusen and pachydrusen: the definition, pathogenesis and clinical significance''.
     Eye (Lond). 2022;36:228.
     PubMed        
     
     

     
     Graefes Arch Clin Exp Ophthalmol

101. DA SILVA RA, Roda VMP, Matsuda M, Siqueira PV, et al
     Cellular components of the idiopathic epiretinal membrane.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1435-1444.
     PubMed         Abstract available
     
     
102. SCOTT IU, Oden NL, VanVeldhuisen PC, Ip MS, et al
     SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1491-1500.
     PubMed         Abstract available
     
     
103. DENG C, Zhao PY, Branham K, Schlegel D, et al
     Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1543-1550.
     PubMed         Abstract available
     
     
104. ZLOTO O, Weisman A, Avisar I, Serlin T, et al
     Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1707-1712.
     PubMed         Abstract available
     
     
105. RIESEN M, Funk J, Toteberg-Harms M
     Long-term treatment success and safety of combined phacoemulsification plus excimer laser trabeculostomy: an 8-year follow-up study.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1611-1621.
     PubMed         Abstract available
     
     
106. KANG HG, Kim JD, Lee J, Byeon SH, et al
     Clinical features, treatment factors, and long-term outcomes of optic disc pit maculopathy.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 21. pii: 10.1007/s00417-022-05661.
     PubMed         Abstract available
     
     
107. ALFAAR AS, Saad A, Wiedemann P, Rehak M, et al
     The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1723-1731.
     PubMed         Abstract available
     
     
108. MEHMED B, Fronius M, Pohl T, Ackermann H, et al
     Electronically monitored occlusion therapy in amblyopia with eccentric fixation.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1741-1753.
     PubMed         Abstract available
     
     
109. DE SOUZA SOARES T, Berezovsky A, Sacai PY, Fernandes AG, et al
     Contribution of objectively measured grating acuity by sweep visually evoked potentials to the diagnosis of unexplained visual loss.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1687-1699.
     PubMed         Abstract available
     
     
110. ALTUNEL O, Irgat SG, Ozcura F
     Objective evaluation of changes in lens clarity after repeated injections of ranibizumab in patients with neovascular age-related macular degeneration.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 21. pii: 10.1007/s00417-022-05668.
     PubMed         Abstract available
     
     
111. HUANG Y, Li X, Ding C, Chen Y, et al
     Comparison of peripheral refraction and higher-order aberrations between orthokeratology and multifocal soft contact lens designed with highly addition.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1755-1762.
     PubMed         Abstract available
     
     
112. KELBSCH C, Stingl K, Jung R, Kempf M, et al
     How lesions at different locations along the visual pathway influence pupillary reactions to chromatic stimuli.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1675-1685.
     PubMed         Abstract available
     
     
113. MILANI P, Mazzola M, Cigada M, Massacesi A, et al
     Algorithm of the major and minor diagnostic criteria for active myopic choroidal neovascularization.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 18. pii: 10.1007/s00417-022-05599.
     PubMed         Abstract available
     
     
114. DOOLING V, Lappas A, Dietlein TS
     Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 18. pii: 10.1007/s00417-022-05655.
     PubMed         Abstract available
     
     
115. TURANZAS NJ, von Holstein SL, Wiencke AK, Toft PB, et al
     Epidemiology and clinical characteristics of congenital choristomas in the ocular adnexa of pediatric patients.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 21. pii: 10.1007/s00417-022-05652.
     PubMed         Abstract available
     
     
116. LIN T, Zhang A, Pazo EE, Hui Y, et al
     Comparable postoperative myopic shift in eyes with retinal vascular diseases and vitreomacular interface diseases after phacovitrectomy.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 18. pii: 10.1007/s00417-022-05656.
     PubMed         Abstract available
     
     
117. LIZA SJ, Choe S, Kwon OS
     Testing the efficacy of vision training for presbyopia: alternating-distance training does not facilitate vision improvement compared to fixed-distance training.
     Graefes Arch Clin Exp Ophthalmol. 2022;260:1551-1563.
     PubMed         Abstract available
     
     
118. CHOW SC, Lam PY, Choy BNK
     Patient-centred care in ophthalmology: current practices, effectiveness and challenges.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 21. pii: 10.1007/s00417-022-05666.
     PubMed         Abstract available
     
     
119. SLAGLE G, Griffin J, Sponsel WE
     Rotational extraction of incarcerated iris (REII): a slit lamp technique to reduce incarcerated iris after nonpenetrating deep sclerectomy for glaucoma.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 20. pii: 10.1007/s00417-022-05670.
     PubMed         Abstract available
     
     
120. ZENG F, Sun Y, Ning N, Lu X, et al
     Risk factors and microbiological characteristics: from bacterial keratitis with hypopyon to keratitis-related endophthalmitis.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 20. pii: 10.1007/s00417-022-05657.
     PubMed         Abstract available
     
     
121. XIA F, Lyu J, Peng J, Zhao P, et al
     Repeated intravitreal ranibizumab for reactivated retinopathy of prematurity after intravitreal ranibizumab monotherapy: vascular development analysis.
     Graefes Arch Clin Exp Ophthalmol. 2022 Apr 19. pii: 10.1007/s00417-022-05628.
     PubMed         Abstract available
     
     

     
     Int Ophthalmol

122. GARZA-GARZA LA, Ramos-Davila EM, Ruiz-Lozano RE, Gutierrez-Juarez K, et al
     Clinical profile of melanocytic lesions of the ocular surface in a Hispanic population.
     Int Ophthalmol. 2022 Apr 19. pii: 10.1007/s10792-022-02266.
     PubMed         Abstract available
     
     
123. RAJENDRABABU S, Puthuran GV, Alia LA, Uduman MS, et al
     Intermediate-term outcomes of combined phacoemulsification and Aurolab aqueous drainage implant in eyes with refractory glaucoma and coexistent cataract.
     Int Ophthalmol. 2022 Apr 20. pii: 10.1007/s10792-022-02251.
     PubMed         Abstract available
     
     
124. LEE JH, Kim HS, Byeon SH, Kim SS, et al
     Clinical characteristics of endogenous Klebsiella pneumoniae endophthalmitis: a 13-year experience.
     Int Ophthalmol. 2022 Apr 17. pii: 10.1007/s10792-022-02301.
     PubMed         Abstract available
     
     
125. LONGO R, Franzolin E, Pedrotti E, Fasolo A, et al
     Glaucoma surgery during the first year of the COVID-19 pandemic.
     Int Ophthalmol. 2022 Apr 16. pii: 10.1007/s10792-022-02278.
     PubMed         Abstract available
     
     

     
     Invest Ophthalmol Vis Sci

126. QI T, Jing R, Ma B, Hu C, et al
     The E3 Ligase RNF157 Inhibits Lens Epithelial Cell Apoptosis by Negatively Regulating p53 in Age-Related Cataracts.
     Invest Ophthalmol Vis Sci. 2022;63:11.
     PubMed         Abstract available
     
     
127. LAN C, Liu G, Huang L, Wang X, et al
     Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
     Invest Ophthalmol Vis Sci. 2022;63:14.
     PubMed         Abstract available
     
     
128. XIE S, Kamoi K, Igarashi-Yokoi T, Uramoto K, et al
     Structural Abnormalities in the Papillary and Peripapillary Areas and Corresponding Visual Field Defects in Eyes With Pathologic Myopia.
     Invest Ophthalmol Vis Sci. 2022;63:13.
     PubMed         Abstract available
     
     
129. VALENCIA E, Garcia M, Fernandez-Vega B, Pereiro R, et al
     Targeted Analysis of Tears Revealed Specific Altered Metal Homeostasis in Age-Related Macular Degeneration.
     Invest Ophthalmol Vis Sci. 2022;63:10.
     PubMed         Abstract available
     
     

     
     J Cataract Refract Surg

130. HUMENNY JA
     Ophthalmic Photographers' Society Exhibit, July 2021.
     J Cataract Refract Surg. 2022;48:507.
     PubMed        
     
     

     
     J Glaucoma

131. OZTURKER Z, Kurt RA
     Effect of Mydriatic Administration On Retinal Hemodynamics in Glaucoma: An Optical Coherence Tomography Angiography Study.
     J Glaucoma. 2022 Apr 14. pii: 00061198-990000000-00015.
     PubMed         Abstract available
     
     
132. JACKSON KJ, Akrobetu D, Guduru A, Herndon LW, et al
     Intracanalicular Dexamethasone Insert or Topical Prednisolone following iStent and Hydrus Surgery for Glaucoma.
     J Glaucoma. 2022 Apr 14. pii: 00061198-990000000-00017.
     PubMed         Abstract available
     
     

     
     J Ocul Pharmacol Ther

133. GHOSN C, Rajagopalan L, Ugarte S, Mistry S, et al
     Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty.
     J Ocul Pharmacol Ther. 2022 Apr 18. doi: 10.1089/jop.2021.0104.
     PubMed         Abstract available
     
     
134. CHOUDHARY M, Ildefonso CJ, Lewin AS, Malek G, et al
     Gene Delivery of a Caspase Activation and Recruitment Domain Improves Retinal Pigment Epithelial Function and Modulates Inflammation in a Mouse Model with Features of Dry Age-Related Macular Degeneration.
     J Ocul Pharmacol Ther. 2022 Apr 19. doi: 10.1089/jop.2022.0002.
     PubMed         Abstract available
     
     
135. FOGAGNOLO P, Romano D, De Ruvo V, Sabella P, et al
     Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery.
     J Ocul Pharmacol Ther. 2022 Apr 18. doi: 10.1089/jop.2021.0123.
     PubMed         Abstract available
     
     

     
     N Engl J Med

136. ROSENBAUM L
     Metric Myopia - Trading Away Our Clinical Judgment.
     N Engl J Med. 2022 Apr 20. doi: 10.1056/NEJMms2200977.
     PubMed        
     
     
137. SUYAMA Y, Akiyama R
     Ocular Gonorrhea.
     N Engl J Med. 2022 Apr 23. doi: 10.1056/NEJMicm2117893.
     PubMed        
     
     

     
     Ophthalmic Plast Reconstr Surg

138. VAHDANI K, Luthert PJ, Rose GE
     Chronic Granulomatous Dacryoadenitis Associated With Pleomorphic Adenoma.
     Ophthalmic Plast Reconstr Surg. 2022;38:e54-e57.
     PubMed         Abstract available
     
     
139. MERBS SL, Talero SL, Tadesse D, Sisay A, et al
     Reply Re: "A New Surgical Technique for Postoperative Trachomatous Trichiasis".
     Ophthalmic Plast Reconstr Surg. 2022;38:212.
     PubMed        
     
     
140. DIAB MM, Allen RC
     Re: "A New Surgical Technique for Postoperative Trachomatous Trichiasis".
     Ophthalmic Plast Reconstr Surg. 2022;38:210-212.
     PubMed        
     
     
141. OZTURKER C, Kaynak P
     Epiphora and Dacryocystitis After Transcanalicular Laser-assisted Dacryocystorhinostomy due to an Undiagnosed Dacryolith.
     Ophthalmic Plast Reconstr Surg. 2022;38:e59-e62.
     PubMed         Abstract available
     
     
142. YU MD, Men CJ, Do H, Colevas AD, et al
     Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
     Ophthalmic Plast Reconstr Surg. 2022;38:e44-e47.
     PubMed         Abstract available
     
     
143. REED DS, Kostosky N, Davies BW, Epstein A, et al
     Rifle Blast Exacerbating Hearing Loss in a Patient Treated With Teprotumumab for Thyroid Eye Disease.
     Ophthalmic Plast Reconstr Surg. 2021 Oct 13. pii: 00002341-900000000-97787.
     PubMed         Abstract available
     
     
144. TONG JY, Powys M, Phan T, Krivanek M, et al
     Pediatric Subcutaneous Panniculitis-like T-cell Lymphoma of the Orbit.
     Ophthalmic Plast Reconstr Surg. 2022;38:e38-e41.
     PubMed         Abstract available
     
     
145. BARRANTES PC, Zhou P, MacDonald SM, Ioakeim-Ioannidou M, et al
     Granular Cell Tumor of the Orbit: Review of the Literature and a Proposed Treatment Modality.
     Ophthalmic Plast Reconstr Surg. 2022;38:122-131.
     PubMed         Abstract available
     
     
146. SMITH LD, Moscato EE, Seiff SR
     Tocilizumab for the Management of Thyroid-Associated Orbitopathy.
     Ophthalmic Plast Reconstr Surg. 2021 Jul 21. pii: 00002341-900000000-97819.
     PubMed         Abstract available
     
     
147. SAINI P, Bothra N, Ali MJ
     Update on the Long-Term Outcomes Following the Management of Incomplete Punctal Canalization.
     Ophthalmic Plast Reconstr Surg. 2022;38:151-153.
     PubMed         Abstract available
     
     
148. NAIR AG, Mukherjee B, Kamal S, Singh S, et al
     Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series.
     Ophthalmic Plast Reconstr Surg. 2022;38:154-159.
     PubMed         Abstract available
     
     

     
     Ophthalmol Glaucoma

149. EL-NIMRI NW, Penteado RC, Bowd C, Proudfoot JA, et al
     Agreement between Compass Fundus Perimeter New Grid and 10-2 Testing Protocols for Detecting Central Visual Field Defects.
     Ophthalmol Glaucoma. 2022;5:179-187.
     PubMed         Abstract available
     
     
150. HENDRICKS TM, Troyer JM, Boese EA
     Tube Placement Along Zonules in Aniridia.
     Ophthalmol Glaucoma. 2022;5:194.
     PubMed        
     
     
151. DOUMAZOS L, Kandarakis SA, Georgalas I
     Unexpected Iris Mass Discovery Revealed after Pupil Dilation.
     Ophthalmol Glaucoma. 2022;5:136.
     PubMed        
     
     
152. DE SAINT SAUVEUR G, Chapron T, Caputo G
     Pre- and Post-Surgical Microspherophakia Anterior-Segment OCT.
     Ophthalmol Glaucoma. 2022;5:31.
     PubMed        
     
     
153. SCHLENKER MB, Ong JA, Wu P, Jinapriya D, et al
     Surgeon Experience as a Risk Factor for Short-Term Failure for Ab Interno Gelatin Microstent: A Canadian Multicenter Propensity-Matched Study.
     Ophthalmol Glaucoma. 2022;5:67-76.
     PubMed         Abstract available
     
     
154. MILLER DJ, Niziol LM, Elam AR, Heisler M, et al
     Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program.
     Ophthalmol Glaucoma. 2022;5:47-57.
     PubMed         Abstract available
     
     
155. SI Z, Theophanous C, Khanna S, Qiu M, et al
     Early Intraocular Pressure Control Via Capsule Revision of a Failed Valved Aqueous Shunt During Concurrent Placement of a Nonvalved Aqueous Shunt.
     Ophthalmol Glaucoma. 2022;5:229-232.
     PubMed         Abstract available
     
     
156. XU C, Chen TC, Chodosh J, Eliott D, et al
     Endoscopic Cyclophotocoagulation in Boston Keratoprosthesis Type II.
     Ophthalmol Glaucoma. 2022;5:120-123.
     PubMed        
     
     
157. AHMED Y, Pereira A, Bowden S, Shi RB, et al
     Multicenter Comparison of the Toronto Portable Perimeter with the Humphrey Field Analyzer: A Pilot Study.
     Ophthalmol Glaucoma. 2022;5:146-159.
     PubMed         Abstract available
     
     

     
     Ophthalmol Retina

158. ZHANG X, Seidelman J, Grewal D, Mahmoud TH, et al
     Methicillin-resistant S. aureus endogenous endophthalmitis retinal detachment repairs.
     Ophthalmol Retina. 2022 Apr 15. pii: S2468-6530(22)00187.
     PubMed         Abstract available
     
     
159. ISHIKURA M, Muraoka Y, Nishigori N, Takahashi A, et al
     Wide Field Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source Optical Coherence Tomography.
     Ophthalmol Retina. 2022 Apr 15. pii: S2468-6530(22)00188.
     PubMed         Abstract available
     
     
160. ZHOU TE, Kassis PO, Qian CX, Berube-Thevenet R, et al
     Reduced contrast sensitivity in young adults that had retinopathy of prematurity.
     Ophthalmol Retina. 2022 Apr 14. pii: S2468-6530(22)00185.
     PubMed         Abstract available
     
     
161. JAFFE GJ, Cameron B, Kardatzke D, Ives J, et al
     Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab.
     Ophthalmol Retina. 2022 Apr 12. pii: S2468-6530(22)00183.
     PubMed         Abstract available
     
     

     
     Ophthalmology

162. COUPLAND S, Kalirai H, Taktak A, Eleuteri A, et al
     Re: Gelmi et al.: Adding The Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System offers more precise prognostication in uveal melanoma (Ophthalmology. 2022:129:431-437).
     Ophthalmology. 2022 Apr 14. pii: S0161-6420(22)00170.
     PubMed        
     
     
163. TOMAR AS, Finger PT, Gallie B, Kivela TT, et al
     High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study.
     Ophthalmology. 2022 Apr 15. pii: S0161-6420(22)00284.
     PubMed         Abstract available
     
     

     
     PLoS One

164. PADAKANDLA SR, Das T, Sai Prashanthi G, Angadi KK, et al
     Gut mycobiome dysbiosis in rats showing retinal changes indicative of diabetic retinopathy.
     PLoS One. 2022;17:e0267080.
     PubMed         Abstract available
     
     
165. CHANG YH, Chien LN, Chen WT, Lin IC, et al
     Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study.
     PLoS One. 2022;17:e0267088.
     PubMed         Abstract available
     
     
166. IIZUKA T, Kawamorita T, Handa T, Ishikawa H, et al
     Refractive and visual function changes in twilight conditions.
     PLoS One. 2022;17:e0267149.
     PubMed         Abstract available
     
     
167. YANG MK, Sa HS, Kim N, Jeon HS, et al
     Quantitative analysis of morphological and functional alterations of the meibomian glands in eyes with marginal entropion.
     PLoS One. 2022;17:e0267118.
     PubMed         Abstract available
     
     
168. IOHAN LDCC, Lambert JC, Costa MR
     Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
     PLoS One. 2022;17:e0266405.
     PubMed         Abstract available
     
     
169. CAVADINI T, Courbois Y, Gentaz E
     Eye-tracking-based experimental paradigm to assess social-emotional abilities in young individuals with profound intellectual and multiple disabilities.
     PLoS One. 2022;17:e0266176.
     PubMed         Abstract available
     
     
170. NIYAZMAND H, Lingham G, Sanfilippo PG, Blaszkowska M, et al
     The effect of transverse ocular magnification adjustment on macular thickness profile in different refractive errors in community-based adults.
     PLoS One. 2022;17:e0266909.
     PubMed         Abstract available
     
     
171. MAHARRAMOV PM, Aghayeva FA
     Evaluation of the effectiveness of combined staged surgical treatment in patients with keratoconus.
     PLoS One. 2022;17:e0264030.
     PubMed         Abstract available
     
     
172. XIAO B, Mercer GD, Jin L, Lee HL, et al
     Outreach screening to address demographic and economic barriers to diabetic retinopathy care in rural China.
     PLoS One. 2022;17:e0266380.
     PubMed         Abstract available
     
     
173. VEDHAKRISHNAN S, Vinas M, Benedi-Garcia C, Casado P, et al
     Visual performance with multifocal lenses in young adults and presbyopes.
     PLoS One. 2022;17:e0263659.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

174. WU W, Takahashi Y, Shin HY, Ma X, et al
     The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation.
     Proc Natl Acad Sci U S A. 2022;119:e2115202119.
     PubMed         Abstract available
     
     
175. WANG Y, Punzo C, Ash JD, Lobanova ES, et al
     Tsc2 knockout counteracts ubiquitin-proteasome system insufficiency and delays photoreceptor loss in retinitis pigmentosa.
     Proc Natl Acad Sci U S A. 2022;119:e2118479119.
     PubMed         Abstract available
     
     
176. XIE L, Cen LP, Li Y, Gilbert HY, et al
     Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells' response to Pten deletion.
     Proc Natl Acad Sci U S A. 2022;119:e2113751119.
     PubMed         Abstract available
     
     
177. GUO D, Ru J, Xie L, Wu M, et al
     Tmem138 is localized to the connecting cilium essential for rhodopsin localization and outer segment biogenesis.
     Proc Natl Acad Sci U S A. 2022;119:e2109934119.
     PubMed         Abstract available
     
     
178. JOFRE DM, Hoffman DK, Cervino AS, Hahn GM, et al
     The CHARGE syndrome ortholog CHD-7 regulates TGF-beta pathways in Caenorhabditis elegans.
     Proc Natl Acad Sci U S A. 2022;119:e2109508119.
     PubMed         Abstract available
     
     

     
     Retina

179. AL-MOUJAHED A, Lin JH, Gagnon MR, Pulido J, et al
     BILATERAL SERPIGINOUS-LIKE CHORIORETINITIS ASSOCIATED WITH CILIOCHOROIDAL MELANOMA: A Clinicopathologic Correlation.
     Retina. 2022;42:824-830.
     PubMed         Abstract available
     
     
180. KANZAKI Y, Doi S, Matoba R, Kanzaki S, et al
     OBJECTIVE AND QUANTITATIVE ESTIMATION OF THE OPTIMAL TIMING FOR EPIRETINAL MEMBRANE SURGERY ON THE BASIS OF METAMORPHOPSIA.
     Retina. 2022;42:704-711.
     PubMed         Abstract available
     
     
181. KHAQAN HA, Sahyoun JY, Muhammad AH, Buksh HM, et al
     AMNIOTIC MEMBRANE GRAFT FOR THE TREATMENT OF LARGE REFRACTORY MACULAR HOLE.
     Retina. 2022 Apr 11. pii: 00006982-990000000-00034.
     PubMed         Abstract available
     
     
182. FEENSTRA HMA, Hahn LC, van Rijssen TJ, Tsonaka R, et al
     EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
     Retina. 2022;42:721-729.
     PubMed         Abstract available
     
     
183. CICINELLI MV, Mastaglio S, Menean M, Marchese A, et al
     Retinal Microvascular Changes in Patients with Acute Leukemia.
     Retina. 2022 Apr 18. pii: 00006982-990000000-00040.
     PubMed         Abstract available
     
     
184. STAPPLER T, Montesel A, Konstantinidis L, Wolfensberger TJ, et al
     Inverted ILM Flap Technique for Macular Hole Coexistent with Rhegmatogenous Retinal Detachment.
     Retina. 2022 Apr 14. pii: 00006982-990000000-00039.
     PubMed         Abstract available
     
     
185. NANJI K, Kherani I, Khan M, Williams G, et al
     A Multicenter Review Evaluating the Risk of Rhegmatogenous Retinal Detachment Post Endophthalmitis: A Canadian Retina Research Network (CR2N) Investigation.
     Retina. 2022 Apr 13. pii: 00006982-990000000-00036.
     PubMed         Abstract available
     
     
186. SPAIDE RF, Valmaggia P, Maloca PM
     Imaging the Vitreous with a Novel Boosted Optical Coherence Tomography Technique: Posterior Vitreous Detachment.
     Retina. 2022 Apr 13. pii: 00006982-990000000-00038.
     PubMed         Abstract available
     
     
187. SRISURIYAJAN P, Cheewaruangroj N, Polpinit P, Laovirojjanakul W, et al
     Cytomegalovirus Retinitis Screening Using Machine Learning Technology.
     Retina. 2022 Apr 11. pii: 00006982-990000000-00032.
     PubMed         Abstract available
     
     
188. CHAN LW, Sung YC, Wu DC, Chen CY, et al
     PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2-RELATED BIETTI CRYSTALLINE DYSTROPHY.
     Retina. 2022;42:797-806.
     PubMed         Abstract available
     
     

     
     Surv Ophthalmol

189. KIRTHI V, Nderitu P, Alam U, Evans JR, et al
     The prevalence of retinopathy in prediabetes: A systematic review.
     Surv Ophthalmol. 2022 Apr 14. pii: S0039-6257(22)00045.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ophthalmology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: